• Featured Product
  • KD/KO Validated

SUCLA2 Polyclonal antibody

SUCLA2 Polyclonal Antibody for IF, IHC, IP, WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IP, IHC, IF, ELISA

Conjugate

Unconjugated

Cat no : 12627-1-AP

Synonyms

A BETA, SCS betaA, SUCLA2



Tested Applications

Positive WB detected inHEK-293 cells, L02 cells, SH-SY5Y cells, HepG2 cells, PC-3 cells, mouse brain tissue, mouse liver tissue
Positive IP detected inHEK-293 cells
Positive IHC detected inhuman colon cancer tissue, human heart tissue, human kidney tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF detected inHepG2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:6000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)IF : 1:50-1:500
Sample-dependent, check data in validation data gallery

Product Information

12627-1-AP targets SUCLA2 in WB, IP, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, rat, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen SUCLA2 fusion protein Ag3319 相同性解析による交差性が予測される生物種
Full Name succinate-CoA ligase, ADP-forming, beta subunit
Calculated molecular weight 463 aa, 50 kDa
Observed molecular weight 48-50 kDa
GenBank accession numberBC027587
Gene symbol SUCLA2
Gene ID (NCBI) 8803
RRIDAB_2271200
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

SUCLA2, β subunit of succinate-CoA ligase, contributes to energy production in mitochondria through the succinate-CoA ligase enzyme. Succinate-CoA ligase catalyses the reversible conversion of succinyl-CoA and ADP or GDP to succinate and ATP or GTP. SUCLA2 mutations cause global protein succinylation and mitochondrial DNA depletion (PMID: 33230181, PMID: 20301762). Mutations in SUCLA2 are also associated with SUCLA2-related mitochondrial DNA depletion syndrome, leigh syndrome, down syndrome (PMID: 23010432).

Protocols

Product Specific Protocols
WB protocol for SUCLA2 antibody 12627-1-APDownload protocol
IHC protocol for SUCLA2 antibody 12627-1-APDownload protocol
IF protocol for SUCLA2 antibody 12627-1-APDownload protocol
IP protocol for SUCLA2 antibody 12627-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Mol Cell

Quantitative subcellular acyl-CoA analysis reveals distinct nuclear metabolism and isoleucine-dependent histone propionylation

Authors - Sophie Trefely
humanWB

Nat Commun

Low chorionic villous succinate accumulation associates with recurrent spontaneous abortion risk.

Authors - Xiao-Hui Wang
mouseWB

Aging Dis

Dietary Salt Disrupts Tricarboxylic Acid Cycle and Induces Tau Hyperphosphorylation and Synapse Dysfunction during Aging

Authors - Minghao Yuan
humanWB,IHC

Oncogene

Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion.

Authors - Susumu Kohno
  • KO Validated
human,mouseWB,IHC

Oncogene

MUC1 triggers lineage plasticity of Her2 positive mammary tumors

Authors - Zhi Pang
humanIF

Brain Struct Funct

Exclusive neuronal expression of SUCLA2 in the human brain.

Authors - Dobolyi Arpád A